Zhejiang Haichang Biotech Co., Ltd.

This study tests a new drug called WGI-0301 combined with lenvatinib in 80 people with advanced liver cancer that hasn't responded to first treatment. The goal is to see if the combination can shrink tumors and how safe it is. Participants will receive both drugs, and researchers…

This study tests a new drug called WGI-0301 combined with nivolumab in people with advanced liver or kidney cancer. The goal is to see if the combination is safe and shows signs of shrinking tumors. About 230 adults aged 18 to 75 will take part at multiple hospitals, with no plac…